RNA as Prognostic Biomarkers in Patients With Acute Coronary Syndrome
ConditionCoronary Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS Policlinico S. Donato
About this trial
Identify circulating protein-coding (mRNAs) or non-coding (ncRNAs) transcripts (ACS\_signature) predictive of ventricular dysfunction in ACS patients undergoing PCI.
Eligibility criteria
Qualifiers
Age >18 years
Patients with ACS (first episode), defined according to the guidelines of the European Society of Cardiology (ESC) 2017
Indication for percutaneous revascularization treatment
Informed consent to study enrollment
Disqualifiers
Severe valve disease or other conditions requiring cardiac surgery
Previous cardiac surgery including coronary artery bypass grafts
Total chronic occlusions
heparin
Trial design
Treatments tested in this trial
- blood draws
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov